Amneal Pharmaceuticals (AMRX) came out with quarterly earnings of $0.17 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +30.77%. A quarter ago, it was expected that this pharmaceutical company would post earnings of $0.18 per share when it actually produced earnings of $0.25, delivering a surprise of +38.89%.Over the last fou ...

Integra LifeSciences (IART) came out with quarterly earnings of $0.54 per share, beating the Zacks Consensus Estimate of $0.43 per share. This compares to earnings of $0.41 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +25.58%. A quarter ago, it was expected that this medical device maker would post earnings of $0.43 per share when it actually produced earnings of $0.45, delivering a surprise of +4.65%.Over the last four qua ...

Chipotle Mexican Grill (CMG) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.28 per share. This compares to earnings of $0.27 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +3.57%. A quarter ago, it was expected that this Mexican food chain would post earnings of $0.32 per share when it actually produced earnings of $0.33, delivering a surprise of +3.13%.Over the last four quart ...

公司概况 - 公司为多元化企业集团 业务涵盖教育、制造业和医疗保健 [1] - 通过战略性投资和收购保持强劲市场地位 [1] - 凭借多元化投资组合推动增长和稳定性 [1] 财务业绩 - 2025年10月29日公布财报 每股收益27.91美元 远超预期的11.23美元 [2] - 营收达12.8亿美元 超过预期的12.2亿美元 [2] - 营收同比增长6% 上年同期为12.1亿美元 [2] 业务板块表现 - 营收增长主要由教育、制造业和医疗保健板块盈利增长驱动 [3] - 尽管其他领域有所下滑 核心板块对公司整体财务健康贡献显著 [3] - 对这些板块的战略聚焦有助于实现财务目标 [3] 估值指标 - 市盈率为6.27 估值相对于盈利具吸引力 [4] - 市销率为1.27 企业价值与销售额比率为1.54 [4] - 指标显示投资者看好公司未来盈利潜力 [4] 财务健康状况 - 债务权益比为0.26 债务水平相对于权益较低 [5] - 流动比率为1.32 表明公司有能力覆盖短期负债 [5] - 盈利收益率为15.95% 为股东提供强劲投资回报 [5][6]

Navient (NAVI) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.28 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +61.11%. A quarter ago, it was expected that this student loan servicing company would post earnings of $0.27 per share when it actually produced earnings of $0.21, delivering a surprise of -22.22%.Over the last four quart ...

Kadant (KAI) came out with quarterly earnings of $2.59 per share, beating the Zacks Consensus Estimate of $2.18 per share. This compares to earnings of $2.84 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.81%. A quarter ago, it was expected that this equipment supplier for the papermaking and paper recycling industries would post earnings of $1.94 per share when it actually produced earnings of $2.31, delivering a surpris ...

Expand Energy (EXE) came out with quarterly earnings of $0.97 per share, beating the Zacks Consensus Estimate of $0.88 per share. This compares to earnings of $0.16 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +10.23%. A quarter ago, it was expected that this oil and gas company would post earnings of $1.14 per share when it actually produced earnings of $1.1, delivering a surprise of -3.51%.Over the last four quarters, the ...

2025年第三季度业绩表现 - 调整后每股收益为3美元 超出Zacks共识预期1.4% 同比增长5.6% [1] - 总营收达41亿美元 略超共识预期 同比增长5.2% [1] - 调整后税息折旧及摊销前利润为9.49亿美元 同比增长1.1% 超出公司预期 [4] 各业务部门收入情况 - 研发部门收入23亿美元 同比增长4.5% 按固定汇率计算增长3.4% 超出公司22亿美元的预期 [3] - 技术与分析部门收入16亿美元 同比增长5% 按固定汇率计算增长3.3% 未达到公司17亿美元的预期 [3] - 合同销售与医疗解决方案收入2.09亿美元 同比增长16.1% 按固定汇率计算增长13.9% 超出公司1.817亿美元的预期 [4] 财务状况与现金流 - 季度末现金及现金等价物为18亿美元 上一季度为20亿美元 [5] - 长期债务（扣除流动部分）为150亿美元 第二季度末为154亿美元 [5] - 经营活动产生的净现金为9.08亿美元 资本支出为1.36亿美元 季度自由现金流达7.72亿美元 [5] 2025年全年业绩指引 - 更新营收指引至161.5亿-162.5亿美元 中点162亿美元高于Zacks共识预期161.6亿美元 [6] - 更新每股收益指引至11.85-11.95美元 中点11.90美元高于共识预期11.86美元 [6] - 调整后税息折旧及摊销前利润指引更新为37.75亿-38.00亿美元 [7] 股价表现 - 过去六个月股价上涨44.9% 表现优于行业13.2%的增长率及Zacks标普500综合指数26.6%的涨幅 [2] 其他公司业绩摘要 - Waste Connections第三季度调整后每股收益1.44美元 超出共识预期4.4% 同比增长6.7% 营收25亿美元同比增长5.1% [8][10] - Equifax第三季度调整后每股收益2.04美元 超出共识预期5.7% 同比增长10.3% 营收15亿美元同比增长6.9% [11]

核心财务业绩 - 第一季度调整后每股收益为1.15美元，同比增长5.5%，超出市场普遍预期的1.12美元 [1] - 季度销售额为211.48亿美元，同比增长3.2%，超出市场预期的210.8亿美元 [1] - 毛利润增长3.9%至39亿美元，毛利率扩大13个基点至18.5% [3][6] 分部运营表现 - 美国食品服务业务销售额增长2.9%至148亿美元，总案例量微增0.1%，本地案例量下降0.2% [4] - 国际食品服务业务销售额增长4.5%至40亿美元，该部门实现了有效的利润率管理、本地销量增长和两位数的利润增长 [5] - 宽线本地业务在本季度表现积极，且在整个季度内逐期改善 [2] 盈利能力与现金流 - 调整后营业收入增长2.9%至8.98亿美元，调整后营业利润率为4.3% [6] - 调整后息税折旧摊销前利润微增0.1%至11亿美元 [6] - 运营现金流为8600万美元，自由现金流为负5000万美元 [7] 财务状况与展望 - 季度末公司持有现金余额8.44亿美元，总流动性为35亿美元 [7] - 公司重申2026财年调整后每股收益指引为4.50至4.60美元，市场共识为4.59美元 [8] - 维持2026财年销售额指引为840亿至850亿美元，市场预期为845.36亿美元 [8]

Arcutis Biotherapeutics, Inc. (ARQT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.1 per share. This compares to a loss of $0.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +160.00%. A quarter ago, it was expected that this company would post a loss of $0.18 per share when it actually produced a loss of $0.13, delivering a surprise of +27.78%.Over the last four qu ...